Pegylated alpha-interferon-2a plus ribavirin compared with pegylated alpha-interferon-2b plus ribavirin for initial treatment of chronic hepatitis C virus: prospective, non-randomized study.

@article{Escudero2008PegylatedAP,
  title={Pegylated alpha-interferon-2a plus ribavirin compared with pegylated alpha-interferon-2b plus ribavirin for initial treatment of chronic hepatitis C virus: prospective, non-randomized study.},
  author={Amparo Escudero and F. Granero Rodr{\'i}guez and Miguel A. Serra and Juan Angel Del Olmo and Francisco Montes and Jose M. Rodrigo},
  journal={Journal of gastroenterology and hepatology},
  year={2008},
  volume={23 6},
  pages={861-6}
}
BACKGROUND AND AIM We assessed whether the two regimens of pegylated alpha-interferon-2b (PEG-IFN-alpha2b) plus ribavirin and pegylated alpha-interferon-2a (PEG-IFN-alpha2a) plus ribavirin showed differences in terms of sustained virological response, withdrawal due to side-effects and dose adjustment requirements in the treatment of naive chronic hepatitis C virus (HCV) patients. METHODS A prospective non-randomized, open-label comparison was made of naive HCV-infected patients undergoing… CONTINUE READING
19 Citations
26 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-10 of 19 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 26 references

Comparison between the two peginterferons alfa in the treatment of chronic hepatitis

  • R Cozzolongo, M Sartori, E Lanzilotta, N Tonello, OG. Manghisi
  • C. Poster 563. 41st Annual Meeting of the…
  • 2007

Estudio comparativo retrospectivo de la eficacia de los interferones pegilados en el tratamiento de la hepatitis crónica C en la práctica clínica habitual

  • J Fuentes, E Sanchez, R Uribarrena-Amezaga
  • Gastroenterol. Hepatol
  • 2007

A randomised trial to compare the pharmacokinetic , pharmacodynamic , and antiviral effects of peginterferon alfa - 2 b and peginterferon alfa - 2 a in patients with chronic hepatitis C ( COMPARE )

  • KP Batts, J Ludwig
  • J . Hepatol
  • 2006

Cost - efficacy analysis of peginterferon alfa - 2 b plus ribavirin compared with peginterferon alfa - 2 a plus ribavirin for the treatment of chronic hepatitis C

  • I Sporea, M Danila, R Sirli, A Popescu, A Laza, L Baditoiu
  • J . Manag . Care Pharm
  • 2005

Similar Papers

Loading similar papers…